Purevax Rabies suspension for injection 1 Dose x 2.
Suspension for injection.
Each 1 ml dose contains: rabies recombinant canarypox virus (vCP65) =106.8 FAID*50
(*Fluorescent assay infectious dose 50%)
Active immunisation of cats aged 12 weeks and older to prevent mortality due to rabies infection.
Onset of immunity: 4 weeks after the primary vaccination course.
Duration of immunity after primary vaccination: 1 year.
Duration of immunity after revaccination: 3 years.
Dosage and administration
1 ml by subcutaneous injection according to the following schedule:
Primary vaccination: 1 injection from 12 weeks of age
Revaccination: 1 year after primary vaccination, then at intervals of up to 3 years.
Travel to countries requiring a rabies serology test: experience has shown that some vaccinated animals, while protected, may not show the 0.5 IU/ml antibody titre required by some countries. Veterinary surgeons may wish to consider two vaccinations. The best time for a blood sample to be taken is around 28 days after vaccination.
Contra-indications, warnings, etc
For animal treatment only. The safety of the product has not been established during pregnancy and lactation.
Transient and slight apathy may occur, as well as occasionally mild anorexia or hyperthermia (above 39.5°C), lasting usually 1 or 2 days. Most of these reactions appeared during the 2 days following the vaccine injection.
A transient local reaction may occasionally occur (pain at palpation, limited swelling that may become nodular, heat at the injection site, and in some cases erythema), that usually disappears within 1 or 2 weeks at most.
Very rarely, a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.
Special precautions for use in animals
Only healthy animals should be vaccinated. Apply usual aseptic procedures.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Canarypox recombinants are known to be safe for humans. Mild local and/or systemic adverse reactions related to the injection itself may be observed transitorily. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Interaction with other veterinary medicinal products and other forms of interaction
Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with Merial PUREVAX non-adjuvanted vaccines containing various combinations of feline viral rhinotracheitis, calicivirosis, panleukopenia and chlamydiosis components.
Based on currently available efficacy data showing a risk of interference, the administration of Merial PUREVAX non-adjuvanted vaccine against feline leukaemia is not recommended within 14 days before or after vaccination with this vaccine.
Keep out of the reach and sight of children.
Use immediately after broaching.
Do not mix with any other veterinary medicinal product except those mentioned in the above ‘Interaction’ section.
Store and transport refrigerated (2°C - 8°C). Protect from light. Do not freeze.
Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.
Box of 2 vials of 1 dose.
Free shipping from Hyperdrug
|Over £49.00||Any Weight||FREE*|
|Under £49.00||Under 250g||£2.49|
|Under £49.00||No weight limit||£4.99|
Estimated " Usually shipped in" information is shown against most products
Postage outside of the UK is from £4.95
Finding out delivery Charges and options before checkout
- Simply add an item to your basket
- Click view basket/Cart
- Click estimate shipping charges